[Inhibition of intestinal leukotriene formation as a possible mechanism of action of sulfasalazine, 5-aminosalicylic acid and 4-aminosalicylic acid]
- PMID: 2907066
- DOI: 10.1007/BF01727854
[Inhibition of intestinal leukotriene formation as a possible mechanism of action of sulfasalazine, 5-aminosalicylic acid and 4-aminosalicylic acid]
Similar articles
-
Sulfasalazine and new analogues.Am J Gastroenterol. 1986 Feb;81(2):141-4. Am J Gastroenterol. 1986. PMID: 2868653 Review. No abstract available.
-
Topical salicylate therapy (4-ASA and 5-ASA enemas).Gastroenterol Clin North Am. 1989 Mar;18(1):35-42. Gastroenterol Clin North Am. 1989. PMID: 2563990 Review.
-
[Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid].Internist (Berl). 1987 Jan;28(1):14-20. Internist (Berl). 1987. PMID: 2883152 German. No abstract available.
-
[Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].Dtsch Med Wochenschr. 1986 May 2;111(18):721-2. Dtsch Med Wochenschr. 1986. PMID: 2870908 German. No abstract available.
-
[New developments in therapy with 5-aminosalicylic acid preparations in ulcerative colitis and Crohn disease].Z Gastroenterol Verh. 1991 Mar;26:154-6. Z Gastroenterol Verh. 1991. PMID: 1714132 Review. German. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical